Cystic fibrosis drug ivacaftor benefits pre-school children
by Bruce Sylvester: Ivacaftor appears to be safe and efficacious for children ages 2 to and 5 with a specific type of cystic fibrosis, researchers reported on Jan…. read more.
by Bruce Sylvester: Ivacaftor appears to be safe and efficacious for children ages 2 to and 5 with a specific type of cystic fibrosis, researchers reported on Jan…. read more.
by Bruce Sylvester: Researchers report that corticosteroids treatment of mothers at risk for late preterm delivery significantly reduces the incidence of severe respiratory complications in their babies.
by Bruce Sylvester: Benzodiazepine therapy in older adults is not associated with an increase in dementia risk, researchers reported on Feb. 2, 2016 in The BMJ today.
by Bruce Sylvester: Researchers report that patients treated with the dementia drug rivastigimine are less likely to fall and are much steadier when walking, compared to patients receiving… read more.
by Bruce Sylvester: Tissue plasminogen activator (tPA) treatment with the clot-busting drug alteplase appears to be an effective way to decrease mortality in intraventricular hemorrhage, a catastrophic type… read more.
by Bruce Sylvester: Investigators from a phase l/II clinical trial report that high-dose atorvastatin treatment of patients with the dry form of age-related macular degeneration (AMD) resulted in… read more.
by Gary Finnegan: Researchers have developed a new scoring system that rates women’s risk of Caesarean section. The study combines a range of indicators to help maternity hospitals… read more.
by Gary Finnegan: HIV is easier than ever to prevent, detect and treat. Yet while life expectancy for people with the virus have improved over the past decade,… read more.
by Gary Finnegan: Good news in the battle against cancer: death rates from leukaemia among people of all ages in Europe are falling.
by Gary Finnegan: Infants that gain weight in their first year of life are more likely to develop type 1 diabetes, according to a study of children born… read more.
by Gary Finnegan: Six new medicines, two of which had been fast-tracked, were given positive reviews from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)…. read more.
by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.